Literature DB >> 16842883

Up-regulation of focal adhesion kinase in non-small cell lung cancer.

Stephana Carelli1, Giorgia Zadra, Valentina Vaira, Monica Falleni, Luca Bottiglieri, Mario Nosotti, Anna Maria Di Giulio, Alfredo Gorio, Silvano Bosari.   

Abstract

Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase linked to the integrin and growth factor receptor-signalling pathways that regulates a number of the biological processes involved in neoplastic transformation, invasion and metastases, such as cell adhesion, migration and apoptosis. Its up-regulation might play a role in the tumourigenesis of invasive tumours, but its involvement in human lung cancer tissues has not yet been determined. We immunohistochemically compared FAK expression and localisation in 60 formalin-fixed and paraffin-embedded non-small cell lung cancer (NSCLC) tissues with that in the surrounding non-neoplastic tissue and in a further five microscopically normal lungs. FAK mRNA levels were quantitatively determined by real-time RT-PCR in frozen tissue specimens of all of the tumours and 21 matched non-neoplastic lung parenchymas, and protein expression in 16 homogenates of the matched neoplastic/non-neoplastic specimens was evaluated by Western blotting. The three different techniques showed that FAK is weakly expressed in non-neoplastic lung parenchyma and up-regulated in NSCLCs. Moreover, Western blotting and real-time RT-PCR indicated a statistically significant correlation between FAK up-regulation and higher disease stages (I+II versus III+IV, p=0.019 and 0.028, respectively). Our results provide evidence that FAK is up-regulated in NSCLCs, and suggest its potential involvement in lung cancer progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842883     DOI: 10.1016/j.lungcan.2006.06.001

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  44 in total

1.  Expression and clinical significance of NEDD9 in lung tissues.

Authors:  Jing-Xia Chang; Feng Gao; Guo-Qiang Zhao; Guo-Jun Zhang
Journal:  Med Oncol       Date:  2012-03-24       Impact factor: 3.064

2.  The prognostic significance of focal adhesion kinase expression in stage I non-small-cell lung cancer.

Authors:  Grace K Dy; Lourdes Ylagan; Saraswati Pokharel; Austin Miller; Elizabeth Brese; Wiam Bshara; Carl Morrison; William G Cance; Vita M Golubovskaya
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

3.  Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma.

Authors:  Miodrag Dragoj; Zorica Milosevic; Jasna Bankovic; Nikola Tanic; Milica Pesic; Tijana Stankovic
Journal:  Cell Oncol (Dordr)       Date:  2016-11-07       Impact factor: 6.730

4.  Overexpression of focal adhesion kinase correlates with increased lymph node metastasis and poor prognosis in non-small-cell lung cancer.

Authors:  Hong-Fei Ji; Da Pang; Song-Bin Fu; Yan Jin; Lei Yao; Ji-Ping Qi; Jing Bai
Journal:  J Cancer Res Clin Oncol       Date:  2012-11-11       Impact factor: 4.553

5.  Expression of focal adhesion kinase in small-cell lung carcinoma.

Authors:  Sebahat Ocak; Heidi Chen; Clay Callison; Adriana L Gonzalez; Pierre P Massion
Journal:  Cancer       Date:  2011-07-28       Impact factor: 6.860

6.  Digital holography of intracellular dynamics to probe tissue physiology.

Authors:  Daniel Merrill; Ran An; John Turek; David D Nolte
Journal:  Appl Opt       Date:  2015-01-01       Impact factor: 1.980

7.  Varied pathways of stage IA lung adenocarcinomas discovered by integrated gene expression analysis.

Authors:  Chengwen Chen; Xuping Fu; Deqiang Zhang; Yuan Li; Yi Xie; Yao Li; Yan Huang
Journal:  Int J Biol Sci       Date:  2011-04-28       Impact factor: 6.580

8.  Expression and clinical significance of focal adhesion kinase in the two distinct histological types, intestinal and diffuse, of human gastric adenocarcinoma.

Authors:  Constantinos T Giaginis; Stephanie Vgenopoulou; Gerasimos S Tsourouflis; Ekaterini N Politi; Gregorios P Kouraklis; Stamatios E Theocharis
Journal:  Pathol Oncol Res       Date:  2008-11-06       Impact factor: 3.201

9.  Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo.

Authors:  Elena V Kurenova; Darell L Hunt; Dihua He; Andrew T Magis; David A Ostrov; William G Cance
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

10.  Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis.

Authors:  Michael K Wendt; William P Schiemann
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.